PTC Therapeutics
PTCT
#2931
Rank
S$7.30 B
Marketcap
S$88.04
Share price
-1.40%
Change (1 day)
49.21%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: S$7.30 Billion

As of May 2026 PTC Therapeutics has a market cap of S$7.30 Billion. This makes PTC Therapeutics the world's 2931th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$7.30 B-9.82%
2025S$8.09 B70.79%
2024S$4.74 B72.63%
2023S$2.74 B-26.45%
2022S$3.73 B-1.91%
2021S$3.80 B-30.9%
2020S$5.50 B37.37%
2019S$4.01 B69.03%
2018S$2.37 B156.34%
2017S$0.92 B70.81%
2016S$0.54 B-65.14%
2015S$1.55 B-30.93%
2014S$2.25 B339.72%
2013S$0.51 B

End of Day market cap according to different sources

On May 23rd, 2026 the market cap of PTC Therapeutics was reported to be:

S$7.30 Billion
by Nasdaq info icon info icon
S$7.30 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
S$371.11 B 4,981.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
S$141.10 B 1,832.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$1.07 B-85.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$2.26 B-68.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
S$0.33 B-95.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
S$14.39 B 97.09%๐Ÿ‡บ๐Ÿ‡ธ USA